Information Disclosure Management System (revised in August 2025)
Shanghai Runda Medical Technology Co., Ltd. Information Disclosure Management System
Shanghai Runda Medical Technology Co., Ltd.
Information disclosure management system
(August 2025)
Chapter 1 General Provisions
Article 1 To protect Shanghai Runda Medical Technology Co., Ltd. (hereinafter referred to as the "Company") and other information disclosure obligors to ensure that the company’s information disclosure is legal, true, accurate, complete and timely, and to protect the legitimate rights and interests of investors. This system is formulated in accordance with relevant laws, regulations, normative documents such as the Corporate Governance Code, the Measures for the Administration of Information Disclosure of Listed Companies, the Stock Listing Rules of the Shanghai Stock Exchange, and the Articles of Association of Shanghai Runda Medical Technology Co., Ltd. (hereinafter referred to as the "Articles of Association").
Article 2 The information that should be disclosed in this system refers to all information that may have a significant impact on the trading prices of the company's securities and their derivatives, as well as information required to be disclosed by relevant laws and administrative regulations or information disclosed by the company on its own initiative.
Article 3 The term “information disclosure” as used in this system refers to the act by which companies and other relevant information disclosure obligors promptly report the information that should be disclosed to the China Securities Regulatory Commission (hereinafter referred to as the “China Securities Regulatory Commission”) and the Shanghai Stock Exchange in accordance with the laws and administrative regulations, and announce it to the public through designated media within the prescribed time and in the prescribed manner.
Article 4 The information disclosure obligors referred to in this system include:
(1) The company’s board of directors, directors and senior managers;
(2) The company’s securities affairs department;
(3) The heads of various departments and subsidiaries of the company;
(4) Shareholders holding more than 5% of the company's shares, the company's controlling shareholders and actual controllers.
(5) Other entities with information disclosure obligations stipulated by laws, administrative regulations and the China Securities Regulatory Commission.
Chapter 2 Basic Principles of Information Disclosure
Article 5 Information disclosure obligors shall perform information disclosure obligations in a timely manner and in accordance with the law, and the information disclosed shall be Shanghai Runda Medical Technology Co., Ltd. Information Disclosure Management System
It must be true, accurate, complete, concise, clear and easy to understand, and shall not contain false records, misleading statements or major omissions. The information disclosed by the information disclosure obligor shall be disclosed to all investors at the same time and shall not be disclosed to any unit or individual in advance. However, unless otherwise provided by laws and administrative regulations.
Before the inside information is disclosed in accordance with the law, insiders of the inside information and persons who illegally obtain the inside information shall not disclose or leak the information, and shall not use the information to conduct insider trading. No unit or individual may illegally require information disclosure obligors to provide information that needs to be disclosed in accordance with the law but has not yet been disclosed.
If securities and their derivatives are publicly issued and traded domestically and overseas at the same time, the information disclosed by the information disclosure obligor in the overseas market shall be disclosed in the domestic market at the same time.
If an information disclosure obligor suspends or exempts information from disclosure, it shall comply with laws, administrative regulations and the provisions of the China Securities Regulatory Commission.
Article 6 The company’s directors and senior managers shall perform their duties faithfully and diligently to ensure that the disclosed information is true, accurate and complete, and that the information disclosed is timely and fair.
Article 7 In addition to the information that needs to be disclosed in accordance with the law, the information disclosure obligor may voluntarily disclose information related to investors' value judgments and investment decisions, but it must not conflict with the information disclosed in accordance with the law, and must not mislead investors.
The information voluntarily disclosed by the information disclosure obligor must be true, accurate and complete. Voluntary information disclosure shall comply with the principle of fairness, maintain the continuity and consistency of information disclosure, and shall not make selective disclosure. Information disclosure obligors shall not use voluntarily disclosed information to improperly affect the trading prices of company securities and their derivatives, and shall not use voluntary information disclosure to engage in other illegal activities such as market manipulation.
Article 8 If the company and its actual controllers, shareholders, related parties, directors, senior managers, acquirers, asset transaction counterparties, bankruptcy reorganization investors and other relevant parties make public commitments, they shall be disclosed in a timely manner and fully fulfilled.
Article 9 Information disclosed in accordance with the law shall be published on the website of the stock exchange and media that meet the conditions specified by the China Securities Regulatory Commission, and shall be placed at the residence of the listed company and the stock exchange for public review.
The full text of information disclosure documents shall be disclosed on the website of the stock exchange and on the websites of newspapers and periodicals that meet the conditions stipulated by the China Securities Regulatory Commission.
Information disclosure obligors shall not replace the reporting and announcement obligations that should be performed in any form such as press releases or answering reporters' questions, and may not replace the temporary reporting obligations that should be performed in the form of regular reports.
Shanghai Runda Medical Technology Co., Ltd. Information Disclosure Management System
During non-trading periods, listed companies and relevant information disclosure obligors may release significant information to the outside world if necessary, but relevant announcements must be made before the start of the next trading period.
Chapter 3 Contents and Standards of Information Disclosure
Article 10 Company information disclosure documents mainly include prospectus, prospectus, listing announcement, periodic reports and temporary reports, etc.
In addition to the information that is compulsorily disclosed in accordance with laws, regulations, rules and the provisions of the Shanghai Stock Exchange, the company has established the principle of voluntary information disclosure. On the basis that it does not involve sensitive financial information or business secrets, the company can proactively and timely disclose information that has a greater impact on the decision-making of shareholders and other stakeholders, including the company's development strategy, business philosophy, and the relationship between the company and its stakeholders.
Section 1 Periodic Report
Article 11 The periodic reports that a company should disclose include annual reports and interim reports.
The content and format of periodic reports shall comply with the regulations of the China Securities Regulatory Commission and the Shanghai Stock Exchange. All information that has a significant impact on investors' value judgments and investment decisions must be disclosed. The financial accounting report in the annual report shall be audited by an accounting firm that complies with the provisions of the Securities Law.
The annual report shall be prepared and disclosed within four months from the end of each fiscal year, and the interim report shall be prepared and disclosed within two months from the end of the first half of each fiscal year.
Article 12 The company’s annual report shall record the following contents:
(1) Basic information of the company;
(2) Main accounting data and financial indicators;
(3) The issuance and changes of the company’s stocks and bonds, the total amount of stocks and bonds, the total number of shareholders at the end of the reporting period, and the shareholding status of the company’s top ten shareholders;
(4) Information about shareholders holding more than 5% of the shares, controlling shareholders and actual controllers;
(5) The employment status, shareholding changes, and annual remuneration of directors and senior managers;
(6) Board of Directors report;
(7) Management discussion and analysis;
(8) Major events during the reporting period and their impact on the company;
(9) The full text of the financial accounting report and audit report;
(10) Other matters prescribed by the China Securities Regulatory Commission.
Article 13 The company’s interim report shall record the following contents:
Shanghai Runda Medical Technology Co., Ltd. Information Disclosure Management System
(1) Basic information of the company;
(2) Main accounting data and financial indicators;
(3) The issuance and changes of the company’s stocks and bonds, the total number of shareholders, the shareholdings of the company’s top ten shareholders, and changes in controlling shareholders and actual controllers;
(4) Management discussion and analysis;
(5) Major litigation, arbitration and other major events during the reporting period and their impact on the company;
(6) Financial accounting reports;
(7) Other matters prescribed by the China Securities Regulatory Commission.
Article 14 The contents of periodic reports shall be reviewed and approved by the company’s board of directors. Periodic reports shall not be disclosed without review and approval by the Board of Directors. The financial information in the periodic reports shall be reviewed by the Audit Committee and submitted to the Board of Directors for review after approval by a majority of all members of the Audit Committee.
If a director cannot guarantee the authenticity, accuracy, completeness or objection of the contents of the periodic report, he shall vote against or abstain from voting when the board of directors considers the periodic report.
If a member of the audit committee cannot guarantee the authenticity, accuracy, completeness or objection of the financial information in the periodic report, he or she shall vote against or abstain from voting when the audit committee reviews the periodic report.
Article 15 The company’s directors and senior managers shall sign a written confirmation of the periodic report, explaining whether the preparation and review procedures of the board of directors comply with laws, administrative regulations and the provisions of the China Securities Regulatory Commission, and whether the content of the report can truly, accurately and completely reflect the actual situation of the listed company.
If directors and senior managers cannot guarantee the authenticity, accuracy, completeness or objection of the contents of the periodic report, they shall express their opinions and state the reasons in a written confirmation opinion, and the company shall disclose it. If the company refuses to disclose, directors and senior managers may directly apply for disclosure.
Directors and senior managers shall abide by the principle of prudence when expressing opinions in accordance with the provisions of the preceding paragraph. Their responsibility to ensure the authenticity, accuracy and completeness of the contents of periodic reports is not only exempted by expressing opinions.
Article 16 If a company expects losses or significant changes in its operating results, it shall make a performance forecast in a timely manner.
Article 17 If performance leaks occur before the disclosure of periodic reports, or performance rumors arise and the company's securities and derivatives transactions experience abnormal fluctuations, the company shall promptly disclose relevant financial data for the reporting period.
Section 2 Interim Report
Article 18 When a major event that may have a greater impact on the trading price of the company's securities and its derivatives occurs and investors have not yet learned of it, the company shall immediately disclose a temporary report to explain the cause and purpose of the event Shanghai Runda Medical Technology Co., Ltd. Information Disclosure Management System
current status and possible impacts.
The major events mentioned in the preceding paragraph include:
(1) Major events specified in paragraph 2 of Article 80 of the Securities Law;
(2) The company is liable for large amounts of compensation;
(3) The company accrues large asset impairment provisions;
(4) The company’s shareholders’ equity is negative;
(5) The company's main debtor becomes insolvent or enters bankruptcy proceedings, and the company fails to withdraw sufficient bad debt provisions for the corresponding claims;
(6) Newly announced laws, administrative regulations, rules, and industry policies may have a significant impact on the company;
(7) The company carries out equity incentives, share repurchases, major asset restructuring, asset spin-offs or listings;
(8) The court rules prohibiting the controlling shareholder from transferring its shares; more than 5% of the company's shares held by any shareholder are pledged, frozen, judicially auctioned, placed in custody, established as a trust, or have voting rights restricted in accordance with the law, or there is a risk of forced transfer;
(9) The main assets are sealed, detained or frozen; the main bank accounts are frozen;
(10) The company expects losses or significant changes in operating results;
(11) Main or all business has come to a standstill;
(12) Obtaining additional income that has a significant impact on current profits and losses may have a significant impact on the company's assets, liabilities, equity or operating results;
(13) Appoint or dismiss the accounting firm that audits the company;
(14) Major independent changes in accounting policies and accounting estimates;
(15) Because the information previously disclosed contains errors, is not disclosed in accordance with regulations, or is falsely recorded, it is ordered to make corrections by relevant authorities or is corrected as decided by the board of directors;
(16) The company or its controlling shareholders, actual controllers, directors, and senior managers are subject to criminal penalties, are investigated by the China Securities Regulatory Commission for suspected violations of laws and regulations, or are subject to administrative penalties by the China Securities Regulatory Commission, or are subject to major administrative penalties by other competent authorities;
(17) The company's controlling shareholders, actual controllers, directors, and senior managers are suspected of serious violations of disciplines and laws or job crimes and are detained by the disciplinary inspection and supervision agencies, which affects their performance of duties;
(18) Except for the chairman or manager, other directors and senior managers of the company are unable to perform their duties normally for more than three months due to physical, work arrangements or other reasons, or are subject to compulsory measures by the competent authority for suspected violations of laws and regulations, which affect their performance of duties;
Shanghai Runda Medical Technology Co., Ltd. Information Disclosure Management System
(19) Other matters prescribed by the China Securities Regulatory Commission.
If a company's controlling shareholder or actual controller has a greater impact on the occurrence or progress of a major event, it shall promptly notify the company in writing of the relevant information it is aware of and cooperate with the company in fulfilling its information disclosure obligations. The company's directors, board of directors, senior managers, the company's controlling shareholders, actual controllers, and heads of the company's departments and subsidiaries should immediately report to the secretary of the board of directors and the company's securities affairs department after learning of the above major events, and the secretary of the board of directors will organize information disclosure.
Article 19 If a company changes its name, stock abbreviation, articles of association, registered capital, registered address, main office address, contact number, etc., it shall disclose it immediately.
Article 20 A company shall promptly perform its information disclosure obligations for major events at any of the following time points that occur first:
(1) When the board of directors forms a resolution on the major event;
(2) When the relevant parties sign a letter of intent or agreement regarding the major event;
(3) When directors and senior managers know or should know that the major event occurs.
If one of the following situations occurs before the time specified in the preceding paragraph, the company shall promptly disclose the current status of relevant matters and risk factors that may affect the progress of the event:
(1) It is difficult to keep the major incident confidential;
(2) The major incident has been leaked or there are rumors in the market;
(3) Abnormal transactions occur in company securities and derivatives.
Article 21 After a company discloses a major event, if there are developments or changes in the disclosed major events that may have a greater impact on the trading prices of the company's securities and derivatives, it shall promptly disclose the progress or changes and possible impacts.
Article 22 If a major event stipulated in Article 23 of the "Measures for the Administration of Information Disclosure of Listed Companies" occurs in a company's controlled subsidiary, which may have a greater impact on the trading price of the listed company's securities and its derivatives, the listed company shall fulfill its information disclosure obligations.
If an event occurs in a company in which the company holds shares that may have a greater impact on the trading prices of listed company securities and their derivatives, the company shall fulfill its information disclosure obligations.
Article 23 If the company's acquisition, merger, division, issuance of shares, repurchase of shares, etc. results in significant changes in the company's total share capital, shareholders, actual controllers, etc., the company shall perform reporting and announcement obligations in accordance with the law and disclose changes in equity.
Article 24 The company should pay attention to the abnormal transactions of the company’s securities and their derivatives and media Shanghai Runda Medical Technology Co., Ltd. Information Disclosure Management System
reports about the company.
When abnormal transactions occur in securities and their derivatives or news appears in the media that may have a significant impact on the trading of the company's securities and its derivatives, the company shall promptly learn the true situation from relevant parties, and when necessary, shall inquire in writing and provide public clarification.
The company's controlling shareholders, actual controllers and persons acting in concert shall promptly and accurately inform the listed company whether there is a proposed equity transfer, asset reorganization or other major events, and cooperate with the listed company in information disclosure.
Article 25 If a company's securities and derivatives transactions are deemed to be abnormal transactions by the China Securities Regulatory Commission or a stock exchange, the company shall promptly understand the factors that cause abnormal fluctuations in securities and derivatives transactions and disclose them in a timely manner.
Chapter 4 Management of Information Disclosure Matters
Article 26 The information disclosure management system is implemented by the company's board of directors. The chairman of the board is the first person responsible for the company's implementation of the information disclosure management system. The secretary of the board of directors is the direct responsible person and specific coordinator of the company's information disclosure management system. The company's securities affairs department is the daily work and management agency for the company's information disclosure affairs. Under the leadership of the board secretary, it is responsible for the company's information disclosure affairs.
Article 27 The secretary to the board of directors is responsible for organizing and coordinating the company's information disclosure affairs, collecting information that the company should disclose and reporting to the board of directors, continuously paying attention to media reports on the company, and proactively verifying the true situation of the reports. The secretary of the board of directors has the right to participate in shareholders’ meetings, board meetings and senior management-related meetings, and has the right to understand the company’s financial and operating conditions, and to review all documents involving information disclosure matters.
The secretary of the board of directors is responsible for handling matters related to the disclosure of company information to the outside world. The information disclosed by the company shall be released in the form of announcement by the board of directors. Directors and senior managers shall not release undisclosed information of the company to the outside world without the written authorization of the board of directors.
The company shall provide convenient conditions for the board secretary to perform his duties, and the financial director shall cooperate with the board secretary in the relevant work of financial information disclosure.
Chapter 5 Responsibilities of Information Disclosure Obligors
Article 28 The company’s directors, board of directors, and senior managers shall be diligent and responsible, pay attention to the preparation of information disclosure documents, ensure that regular reports and temporary reports are disclosed within the prescribed period, cooperate with the company and other information disclosure obligors to perform information disclosure obligations, and ensure that the company’s information disclosure content is true, accurate, and Shanghai Runda Medical Technology Co., Ltd. Information Disclosure Management System
Complete.
The company's chairman, general manager, and board secretary shall bear primary responsibility for the authenticity, accuracy, completeness, timeliness, and fairness of the information disclosed in the company's interim reports.
The company's chairman, general manager, chief financial officer, and head of the accounting department shall bear primary responsibility for the authenticity, accuracy, completeness, timeliness, and fairness of the company's financial accounting report disclosures.
The company's financial management center and securities affairs department should cooperate with the secretary of the board of directors in information disclosure to ensure that the company's regular reports and temporary reports on major asset restructuring can be disclosed in a timely manner.
Article 29 The company's audit committee is responsible for supervising the implementation of the company's information disclosure management system, and shall supervise the performance of information disclosure responsibilities by the company's directors and senior managers; pay attention to the company's information disclosure and discover that there are any illegal or illegal issues in information disclosure, it shall conduct an investigation and make suggestions for handling;
Article 30 The company's senior managers shall report to the board of directors in a timely manner major events in the company's operations or finances, the progress or changes in disclosed events, and other relevant information.
Article 31 The company’s general manager, financial director, board secretary and other senior management personnel shall prepare drafts of periodic reports in a timely manner and submit them to the board of directors for review; the board secretary is responsible for delivering them to directors for review; the chairman is responsible for reviewing, convening and presiding over board meetings to review periodic reports; the board secretary is responsible for organizing the disclosure of periodic reports. Directors and senior managers should actively pay attention to the progress of the preparation, review and disclosure of periodic reports, and should immediately report to the company's board of directors any situation that may affect the disclosure of periodic reports on schedule. Before the periodic report is disclosed, the board secretary shall notify the directors and senior managers of the periodic report draft.
Article 32 Directors and the board of directors, senior managers, heads of various departments of the company, subsidiaries, controlling shareholders of the company, actual controllers and other persons acting in concert shall cooperate with the secretary of the board of directors in the information disclosure work, and provide convenience for the secretary of the board of directors and the securities affairs department to perform their duties.
Article 33 The company’s directors, senior managers, shareholders holding more than 5% of the shares, and persons acting in concert and actual controllers shall promptly submit to the company’s board of directors a list of the company’s related persons and an explanation of the related relationships. The company shall perform the review procedures for related-party transactions and strictly implement the voting avoidance system for related-party transactions. The parties to the transaction shall not conceal the related relationship or use other means to circumvent the company's related transaction review procedures and information disclosure obligations.
Article 34 When the following events occur to a company’s shareholders or actual controllers, they shall proactively inform the company’s board of directors and cooperate with the listed company in fulfilling its information disclosure obligations:
(1) Shareholders or actual controllers holding more than 5% of the company’s shares hold shares or control Shanghai Runda Medical Technology Co., Ltd. Information Disclosure Management System
There are major changes in the company's situation, and there are major changes in the company's actual controller and other companies it controls that are engaged in the same or similar business as the company;
(2) The court rules prohibiting the controlling shareholder from transferring its shares, and more than 5% of the company's shares held by any shareholder are pledged, frozen, judicially auctioned, placed in custody, established as a trust, or have voting rights restricted in accordance with the law, or there is a risk of forced transfer;
(3) Planning to carry out major asset or business reorganization of the company;
(4) Other circumstances specified by the China Securities Regulatory Commission.
Before the information that should be disclosed is disclosed in accordance with the law, the relevant information has been disseminated in the media or there are abnormal transactions in the company's securities and derivatives, the shareholders or actual controllers shall make a timely and accurate written report to the company, and cooperate with the company to make timely and accurate announcements.
Shareholders and actual controllers of a company shall not abuse their shareholder rights and dominant position, or require the company to provide them with inside information.
Article 35 When a company issues stocks to specific objects, its controlling shareholders, actual controllers and issuing objects shall provide relevant information to the company in a timely manner and cooperate with the company in fulfilling its information disclosure obligations.
Article 36 When a company inquires or investigates relevant situations and information from shareholders, controlling shareholders or actual controllers holding more than 5% of the shares, the relevant parties shall respond in a timely manner, provide relevant information, and confirm or clarify relevant facts. Shareholders and actual controllers holding more than 5% of the shares should ensure that the responses, materials and information they provide to the company are true, accurate and complete, and designate a dedicated person to respond to matters related to the company's information disclosure.
Article 37 The draft of temporary announcement shall be drafted by the company's securities affairs department, and shall be submitted to the chairman of the company for approval after being reviewed by the secretary of the board of directors. Temporary announcements shall be promptly notified to directors and senior managers.
Chapter 6 Confidentiality Measures and Responsibilities
Article 38 The company has formulated the "Registration and Management System for Insiders of Insider Information" and adopts strict confidentiality measures for important undisclosed information. Insiders of a company's inside information refer to units and relevant personnel who directly or indirectly obtain inside information before the company's inside information is publicly disclosed, including but not limited to company directors and senior managers, shareholders holding more than 5% of the company's shares and their directors and senior managers, etc.
Article 39 Directors, senior managers and other staff members who have access to inside information due to work relationships are obliged to keep it confidential and shall not disclose it to the outside world in any form without authorization.
Article 40 Company directors, senior managers and other insiders of inside information shall take necessary measures Shanghai Runda Medical Technology Co., Ltd. Information Disclosure Management System
Implementation measures to minimize the number of insiders of insider information before it is publicly disclosed.
Article 41: In business cooperation with various intermediary agencies, various departments of the company shall only exchange information within this system and shall not leak or illegally obtain other inside information unrelated to the work.
Article 42 Relevant departments of the company should carefully review reports at large-scale important internal meetings of the company, speeches and written materials at meetings held by the controlling shareholders; if public information is involved but has not been disclosed in the designated media and cannot be avoided, the scope of communication should be limited and confidentiality requirements should be imposed on the report drafters and participants. During the company's normal working meetings, participants have the responsibility to keep confidential the important information stipulated in this system.
Chapter 7 Internal Control and Supervision Mechanism of Financial Management and Accounting
Article 43 The company's financial management center is responsible for the company's financial management and accounting, promptly reports to the board of directors on the establishment and implementation of the company's financial management and accounting system, and is responsible for providing financial data on financial matters and related matters that meet the information disclosure requirements to the Securities Affairs Department and the secretary of the board of directors.
Article 44 The company shall implement an internal audit system and assign auditors to conduct internal audit supervision over the company's financial management and accounting. The company's internal audit system and auditors' responsibilities shall be implemented after approval by the board of directors. The person in charge of the audit is responsible and reports to the board of directors.
Chapter 8 Review and Disclosure of Company Information
Article 45 The secretary of the company's board of directors is responsible for organizing and arranging the uploading of announcements and relevant filings on the exchange, and completing the external disclosure process.
Article 46 Procedures for the preparation, review and disclosure of the company’s periodic reports:
(1) The secretary of the board of directors organizes various departments of the company to provide business information required for regular reports;
(2) The Securities Affairs Department and the Finance Department will cooperate to complete the preparation and content review and proofreading of regular reports;
(3) The secretary of the board of directors is responsible for delivering it to the directors for review;
(4) The audit committee shall review regular reports and submit them to the board of directors for review;
(5) All directors and senior managers of the company issue written confirmation opinions on the periodic report, and the chairman of the board signs and confirms the full text of the periodic report;
(6) The secretary of the board of directors is responsible for organizing the disclosure of regular reports.
Article 47 The company’s interim report shall follow the following procedures:
(1) When a major event occurs in the company, the relevant information disclosure obligors shall immediately follow the company’s regulations Shanghai Runda Medical Technology Co., Ltd. Information Disclosure Management System
fulfill reporting obligations;
(2) When the secretary of the board of directors learns that information should be disclosed, he should immediately report it to the chairman of the board of directors, or organize the drafting of disclosure documents based on the resolutions of the board of directors and shareholders' meeting;
(3) The secretary of the board of directors is responsible for conducting procedural reviews and organizing the disclosure of interim reports.
Article 48 The company may communicate with investors, securities service agencies, media, etc. on the company’s operating conditions, financial status and other events through performance briefings, analyst meetings, road shows, investor surveys, etc., but shall not provide inside information.
Article 49 The Securities Affairs Department is responsible for drafting the reports submitted by the company to the securities regulatory authorities, and the Secretary to the Board of Directors is responsible for reviewing them. The company's promotional documents must be approved by the secretary of the board of directors before being released to the public to prevent the company's undisclosed information from being leaked in promotional documents.
Chapter 9 Communication with investors, securities service institutions, media, etc.
Article 50 The secretary of the board of directors shall be the person in charge of investor relations activities.
Article 51 Complete files should be established for investor relations activities. The files of investor relations activities should at least include the participants, time, location, content, etc. of the investor relations activities. Such files shall be kept by the secretary of the board of directors.
Article 52 A company shall pay attention to abnormal transactions in its securities and derivatives and media reports about the company. If the news spread by public media may or has had a greater impact on the trading price of the company's stocks and its derivatives, the company shall promptly provide the Shanghai Stock Exchange with evidence of the spread of the relevant news and issue a clarification announcement. At the same time, the company shall communicate and clarify with the relevant media as soon as possible.
Article 53 When institutional investors, analysts, personnel from securities service agencies, news media and other specific parties come to the company for on-site visits and discussions, the company shall prevent the visitors from having the opportunity to obtain undisclosed information.
Chapter 10 File Management of Documents and Materials Related to Information Disclosure
Article 54 The Securities Affairs Department is responsible for keeping external information disclosure documents and materials, including original prospectuses, listing announcements, periodic reports, temporary reports, relevant contracts, agreements, resolutions and records of shareholders’ meetings, resolutions and records of the board of directors, and other materials.
Article 55 To review the originals and drafts of documents and materials related to information disclosure, the inquirer shall submit a written inquiry application to the Securities Affairs Department, indicating the inquiry time, inquiry matters, inquiry reasons, etc. The inquiry may only be made with the consent of the secretary of the board of directors.
Shanghai Runda Medical Technology Co., Ltd. Information Disclosure Management System
Chapter 11 Information disclosure management involving various departments and subsidiaries of the company
Article 56 The person in charge of each department of the company shall urge the department to strictly implement this system and ensure that any major information that should be disclosed in the department or the subsidiary itself (including matters that cannot be determined to constitute major information) are promptly reported to the company's securities affairs department and the secretary of the board of directors. All departments and subsidiaries of the company should fully cooperate according to the company's requirements during the company's preparation of periodic reports, and provide relevant financial, operational, corporate governance and other information on the company's departments and subsidiaries in a timely manner.
Article 57 Each department and subsidiary of the company shall designate a designated person as a liaison person to be responsible for information disclosure, and promptly report information related to the department and subsidiary to the secretary of the board of directors and the Securities Affairs Department.
Chapter 12 Responsibilities and Punishments
Article 58 If the negligence of a party involved in information disclosure involved in this system results in information disclosure violations that cause serious impact or loss to the company, the responsible person shall be criticized, warned, or even dismissed from his or her position, and appropriate compensation requirements may be made to him or her.
Article 59 If relevant personnel violate information disclosure regulations and the disclosed information contains false records, misleading statements or major omissions, causing losses to others, they shall bear administrative liability and civil compensation liability in accordance with the law. If a crime is constituted, legal liability shall be pursued in accordance with the law.
Article 60 Consultants, intermediary agency staff, related persons, etc. hired by the company are also responsible for confidentiality. If the company information is disclosed without authorization and causes losses to the company, the company reserves the right to pursue their liability.
Chapter 13 Supplementary Provisions
Article 61 The terms “above” and “less than” mentioned in this system include the original number; “more than” and “less than” do not include the original number.
Article 62 If any matter is not covered in this system or conflicts with the relevant provisions of national laws, regulations, normative documents and the "Articles of Association", the relevant provisions of the national laws, regulations, normative documents and the "Articles of Association" shall apply.
Article 63 The Board of Directors is responsible for revising and interpreting this system.
Article 64 This system shall take effect from the date of review and approval by the company's board of directors, and the original system shall be abolished from the same date.